Skip to content

Rydapt

Rydapt comes in 1 pill version in our database, in 1 strength, from 1 manufacturer. Check the imprint to tell them apart.

Rydapt pill images

25 mg 1 pill

What is Rydapt used for?

Rydapt is used for acute myeloid leukemia, hematologic neoplasms and systemic mastocytosis.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Acute Myeloid Leukemia

RYDAPT is indicated in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive, as detected by an FDA approved test.

Limitations of Use

RYDAPT is not indicated as a single-agent induction therapy for the treatment of patients with AML.

Systemic Mastocytosis

RYDAPT is indicated for the treatment of adult patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

From the FDA-approved label on DailyMed (published Jun 10, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.